Neurodegeneration
In Parkinsons 2026, this session focuses on the progressive loss of neurons that defines Parkinsons disease, with an emphasis on the degeneration of dopaminergic cells in the brain. It explores the cellular and molecular processes driving neuronal damage, including protein aggregation, mitochondrial dysfunction, and impaired cellular repair mechanisms. The session highlights emerging connections between Parkinsons, Genetics, Alzheimer, Surgery, and Epidemiology, providing a broader understanding of disease mechanisms and clinical outcomes.
Tracks:
Track 5.1: Neuronal Loss
Track 5.2: Dopaminergic Neurons
Track 5.3: Alpha Synuclein
Track 5.4: Protein Aggregation
Track 5.5: Mitochondrial Damage